tiprankstipranks

TOT BIOPHARM Announces 2025 AGM Details and Key Resolutions

Story Highlights
TOT BIOPHARM Announces 2025 AGM Details and Key Resolutions

Don’t Miss TipRanks’ Half-Year Sale

TOT BIOPHARM International Co. Ltd. ( (HK:1875) ) just unveiled an announcement.

TOT BIOPHARM International Co. Ltd. has announced the details of its upcoming annual general meeting, scheduled for June 20, 2025. The meeting will address several key resolutions, including the approval of the company’s financial statements for 2024, the re-election of board members, and the reappointment of PricewaterhouseCoopers as auditors. Additionally, the meeting will consider authorizing the board to manage the company’s share capital, which could impact the company’s financial strategy and shareholder value.

The most recent analyst rating on (HK:1875) stock is a Buy with a HK$3.00 price target. To see the full list of analyst forecasts on TOT BIOPHARM International Co. Ltd. stock, see the HK:1875 Stock Forecast page.

More about TOT BIOPHARM International Co. Ltd.

TOT BIOPHARM International Co. Ltd. is a company incorporated in Hong Kong, operating in the biopharmaceutical industry. It focuses on the development, manufacturing, and commercialization of oncology drugs, aiming to provide innovative treatments for cancer patients.

Average Trading Volume: 165,256

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.39B

For an in-depth examination of 1875 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1